Neurocrine Biosciences (NASDAQ:NBIX) Raised to Strong-Buy at StockNews.com
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued on Monday. A number of other analysts have also recently issued reports on the company. Morgan Stanley increased their price objective on Neurocrine Biosciences from $170.00 to $185.00 […]
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued on Monday. A number of other analysts have also recently issued reports on the company. Morgan Stanley increased their price objective on Neurocrine Biosciences from $170.00 to $185.00 […]
